Pediatric concealed penis
Conditions
Interventions
control group:0.2% ropivacaine injected around the base of the penis
trial group:0.2% ropivacaine injected in the sacral canal
Sponsors
Heping Surgery Hospital of Shunde
Eligibility
Sex/Gender
Male
Age
3 Years to 14 Years
Inclusion criteria
Inclusion criteria: 1. The diagnostic criteria of concealed penis were met: (1) The penis was shorter in appearance than that of the peers, but its development was normal; (2) The normal penis was exposed by squeezing the skin of the root of the penis backward, and then retracted rapidly after loosening; (3) Other genital deformities were excluded; (4) Obesity caused the body of the penis to be partially buried under the prepubic fat; 2. All patients received surgical treatment; 3. The patient's primary guardian gave informed consent to the choice of analgesia; 4. The patient aged < 14 years; 5. The informed consent was signed.
Exclusion criteria
Exclusion criteria: 1. Children with other serious heart, liver and kidney diseases; 2. Children with nervous system diseases; 3. Children allergic to narcotic drugs; 4. Mental disorders or cognitive dysfunction; 5. Observers who did not complete the study as required for various reasons, with incomplete observation records; 6. Very poor compliance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Heart rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Breathing;Adverse reactions;Dose of ropivacaine;Length of hospital stay;The cost;Post-surgical pain;Satisfaction; | — |
Countries
China
Contacts
Public ContactLin Zhuopeng
Heping Surgery Hospital of Shunde
Outcome results
None listed